This article addresses concepts of environmental tobacco smoke (ETS) exposure assessment relevant for health risk assessment based on human studies. We present issues that should be considered when selecting a method for ETS exposure assessment for the purposes of health risk assessment and review data on ETS exposure levels in the workplace and in home environments. Two types of estimates are needed for a quantitative risk assessment of the health effects resulting from occupational ETS exposure: a) an unbiased estimate of the exposure-effect (or dose-response) relation between ETS and the health effect of interest, and b) estimates of the distribution of ETS exposure in different workplaces. By combining the estimated exposure-effect relation with information on exposure distribution for a population of interest, we can calculate the proportions of disease cases attributable to occupational ETS exposure as well as the excess number of cases due to specified exposure conditions. Several dimensions of the exposure profile should be considered when assessing ETS exposure for estimating the exposure-effect relation, including the magnitude of exposure and the biologically relevant time specificity of exposure. The magnitude of exposure is determined by the ETS source strength, environmental factors modifying concentrations, and duration of exposure. Time specificity considerations include the latency period for each health outcome of interest, the time-exposure profile relevant for different disease mechanisms, and the sensitive age period with regard to health effects. The most appropriate indicator of ETS exposure depends on these factors and on the time period that can be assessed with different methods. Key words: exposure assessment, risk assessment, tobacco smoke pollution, workplace exposure. - 
Exposure assessment is an essential element of the evaluation of health risks of environmental exposures. In this article, we consider exposure assessment for environmental tobacco smoke (ETS), with emphasis on occupational settings. Substantial research on the adverse health effects of ETS has already accumulated (1) (2) (3) (4) . Many of the studies have been directed at exposures in residences and involve the effects of smoking in the household on nonsmoking spouses and children, whereas much less data are available on the effects ofoccupational ETS exposure. This workshop evaluated the evidence on potential health effects resulting from ETS exposure in the workplace.
In this article, we consider the exposure information needed to conduct an informative risk assessment of the health effects of ETS based on human studies, whether epidemiologic or clinical. We (5) . First, we consider fundamental concepts related to exposure. Concentration refers to the amount of a contaminant at a particular location in a particular medium, e.g., in a specified volume of air (6) . ETS is a mixture of gaseous compounds and particles composed of concentrations of several individual constituents. Air pollutant concentrations are usually expressed as mass per unit volume, e.g., micrograms per cubic meter. Exposure is defined as the contact of pollutant with a susceptible surface of the human body (6) (7) (8) . For ETS this definition implies contact with the eyes, the epithelium of the nose, mouth, and throat, and the lining of the airways and alveoli. With respect to time, exposure can be expressed on several time scales, including instantaneous exposure, average exposure over a specified time period, and cumulative exposure (8, 9) . Dose is defined as the amount of contaminant that crosses a boundary of the body (6, 7, 10) . Dose depends on the concentration at which exposure is received, the time course of exposure, and the physiologic state of the individual.
The amount of the pollutant absorbed constitutes the dose to the body, and the amount that reaches the target organ of the adverse effect is the biologically effective dose.
The Chain Linking ETS Sources to Health Effects Figure 1 [from Jaakkola and Jaakkola (9) ] presents the chain that links the sources of ETS to the exposure of an individual and finally to the biologically effective dose. The number of smokers and their smoking patterns in a given space determine the source strength for ETS. The source strength is a major determinant of the concentration of ETS in a given space, but the concentration is also determined by characteristics of the space, including the volume of the space, the ventilation rate, and other factors affecting removal of ETS such as air cleaning. By combining the estimated exposureeffect relation with information on exposure distribution for a population of interest, we can calculate the proportions of the exposed disease cases (attributable proportion or etiologic fraction) and of all disease cases in this population (population-attributable proportion) attributable to occupational ETS exposure. We can also estimate the excess number of cases due to specified exposure conditions.
Next we discuss important issues that should be considered when selecting an ETS exposure assessment method for estimating the exposure-effect relation and review currently available data on workplace and residential ETS exposures.
Selection of ETS Exposure Assessment Method for Estimating Health Effects
When estimating health effects of ETS exposure, two dimensions in the ETS exposure profile should be considered (9): quantitative assessment of exposure and time specificity of exposure in relation to outcome. Quantitative ETS exposure assessment includes the magnitude of ETS concentration, the duration of exposure, and the time pattern of exposure (changes in the exposure level over time). The time period of interest depends on the health outcome.
A key issue concerning the time specificity of exposure is the biologically relevant exposure for each health outcome of interest. Three aspects of the time specificity of exposure should be considered. First, the latency period, or the time period from start of exposure to manifestation of the health outcome, may vary from a few hours for exacerbation of asthma to 20 years or more for lung cancer. Second, the relevant exposure-time profile may vary considerably from one disease to another. For example, high but brief peak levels may be relevant for exacerbations of asthma, whereas development of lung cancer likely reflects cumulative exposure over long time periods. Third, for some health outcomes there may be susceptible age or maturation windows during which exposure may cause disease, whereas similar exposure during another period may have less risk or possibly no effect. For example, the sensitive period may be relevant when assessing the adverse effects of a mother's occupational exposure on the fetus or of household smoking on lung development of infants. (1, 9, 11) . Methods for ETS exposure assessment are divided into direct and indirect methods. These methods are described in more detail in a recent article by Jaakkola and Jaakkola (9) (9) . Vapor-phase nicotine is the most commonly used marker for the gas-phase constituents of ETS. Other markers of the gas phase include carbon monoxide (CO), nitrogen oxides, formaldehyde, and volatile organic compounds (1, 12 (4, 12) . The advantages related to using nicotine and RSPs as markers have been availability of validated and easy measurement methods, knowledge of their emission rates from tobacco combustion, and knowledge of their relations to other ETS components (1, 9) . In addition, the presence of nicotine in air is specific to tobacco combustion.
Questionnaire-based assessment is the most widely used exposure assessment method in epidemiologic studies of the health effects of ETS. Questionnaires are relatively inexpensive and can be used to assess longterm ETS exposure, even focusing on past exposures (9) . Questionnaires have been developed to improve exposure assessment by considering time specificity of exposure as well as quantification of exposure (13) (14) (15) . Biomarkers can be considered surrogate measures of dose. However, the relation between exposure and the level of a biomarker is often complex, as it is modified by the various factors presented in Figure 1 . Cotinine, one of the major metabolites of nicotine, has been used commonly as a biomarker for both active smoking and ETS exposure. In adult nonsmokers, its half-life is from 7 to 40 hr (1, 16) , and it can be measured in plasma, urine, and saliva. Hair nicotine content is a relatively new biomarker of ETS that has the advantage of representing tobacco smoke exposure during the previous 1 to 2 months (17). Adsorption of nicotine from the surrounding air onto hair appears to be the primary contributor to the overall nicotine content in the hair, so hair nicotine represents exposure rather than dose (18) .
Recent reports have assessed protein and DNA adducts as markers of ETS exposure (4) . The compound 4-aminobiphenyl (4-ABP) is a known human carcinogen, and its adduct of hemoglobin has a half-life of approximately 4 months (1). Elevated levels of 4-ABP adduct have been observed in association with ETS exposure (19, 20 Table 2 presents, according to our judgment, the most likely latency periods for effects of ETS exposure on four major diseases of interest. Development of new disease and exacerbation of established disease are considered separately for asthma and coronary heart disease (CHD). The latency periods cover a full spectrum-from hours for exacerbation of asthma and angina, to days for exacerbation of asthma, to months for induction of asthma and low birth weight, and to years for induction of asthma, CHD, and lung cancer. questionnaire-derived time-activity data.
Cumulative exposure over long time periods could be assessed with hair nicotine content, 4-ABP hemoglobin adduct levels, or indices based on questionnaire information.
Some markers might be particularly relevant for specific health effects depending on the phase of ETS represented by the marker, the site of deposition, and the target tissue ultimately reached by the marker. 
ETS Levels in the Work and Residential Environments Comparison ofthe Indoor Air Concentrations ofETS Markers
Since most epidemiologic data on health effects of ETS come from studies assessing ETS exposure at home, we review and compare data available on ETS levels in both work and residential environments. Two reviews on the topic were published in 1992 (1, 12) . In addition, U.S. studies on ETS exposure in the workplace and home were summarized recently by Hammond (25) . Guerin and co-workers (12) reviewed major studies, defined as those with at least 15 observations, that had measured air nicotine and/or RSP concentrations in different environments. A summary of these findings is presented in Table 4 . The average air nicotine levels were comparable between residential environments and work situations other than office work but slightly lower in office environments. The highest nicotine levels have been observed in bars and restaurants or in small enclosed spaces with minimal ventilation, e.g., small offices, cars, and aircraft. Indoor RSP concentrations associated with smoking occupancy were also comparable between residential environments and work environments other than offices, but the upper range of mean concentrations was slightly lower in offices. The RSP values in Table 4 were achieved by subtracting the average level in nonsmoking environments from that observed in the smoking environments for each study. RSP levels in nonsmoking households were about half or less those related to smoking occupancy. Figures 3 and 4 show the range of average nicotine and RSP concentrations as well as the range of maximum and minimum values from smoking occupancy by different indoor environments, according to the review by U.S. Environmental Protection Agency (1) . Only studies with sampling times of 4 hr or greater were included in the residential and office environments. The mean nicotine concentrations were comparable between home and office environments, whereas the maximum concentrations were higher in office environments. The mean and maximum RSP concentrations were somewhat higher in residential than in office environments. (26) . Among ETS-exposed housewives and househusbands, the mean 24-hr concentration of nicotine was 3.1 ,ug/m3 (range, 0.2-7.5 ,ug/m3); the mean 24-hr concentration of RSP was 51 pg/m3 (range, pg/m3). Among the working subjects, the mean concentrations for ETS exposure in the home (sampling outside of work hours; mean, 15 hr) were 0.3 pg/m3 (range, 0.1-1.6 pg/m3) for nicotine and 27 pg/m3 (range, 7.4-63 pg/m3) for RSP. The mean concentrations for work exposure (sampling during work hours; mean, 7 hr) were 0.5 pg/m3 (range, 0.1-3.1 pg/m3) for nicotine and 24 pg/m3 (range, 9.7-70 pg/m3) for RSP. In a large study of 16 metropolitan areas of the United States in 1993-1994, personal sampling was performed in 1,498 subjects representing a variety of occupations in both office and nonoffice environments (27) . The smoking status of the environment was first classified by response to a screening questionnaire, then confirmed by a diary report. Subjects with salivary cotinine levels of 15 ng/mL or more were excluded as potential active smokers. The mean 8-hr nicotine and RSP concentrations related to ETS exposure in the workplace were 2.4 pg/m3 (95th percentile, 10.8 pg/m3) and 49.4 pg/m3 (95th percentile, 145 pg/m3), respectively. The corresponding mean 16-hr concentrations related to home exposure (nonwork exposure including possible exposures while shopping, commuting, dining out, etc.) were 2.7 pg/m3 (95th percentile 7.9 pg/m3) and 44.1 pg/m3 (95th percentile, 125 pg/m3), respectively. Table 5 presents a summary of the geometric mean and median air nicotine concentrations as well as the range of concentrations in different occupational settings and in homes in the United States, according to the recent review by Hammond (25) . The values for occupational concentrations are from measurements in work areas of nonsmokers. The mean nicotine concentrations in offices allowing smoking were generally between 2 and 6 pg/m3, and in diverse blue-collar occupations mean concentrations were between 1 and 6 pg/m3, although some workplaces had higher means. In homes of smokers, the mean nicotine concentrations were generally between 1 and 3 pg/m3, indicating slightly lower ETS exposure levels in residential than in work environments. The mean and median concentrations were somewhat higher in office environments than in other work environments, probably attributable to the larger size and better ventilation of the nonoffice work areas. In a large study of 25 Massachusetts work sites, including office environments and different production work areas, work site smoking policy had a strong effect on indoor air nicotine concentrations (28) . The median values in offices were (29) . Indoor concentrations of RSP, CO, or nicotine have been measured to validate these models, and good agreement was seen between observed and predicted indoor concentrations (29) (30) (31) (32) . In a recent article including theoretical considerations and a review of previous studies, Ott concluded that cigarette smoking is well suited for making accurate predictions of marker concentrations applying the mass balance law (29) , which is stated as follows: "The average concentration in a well-mixed indoor setting is computed as the source strength divided by the product of the volume of the setting and the air change rate of the setting." Table 6 presents estimates of the relation between questionnaire-reported smoking rate in residences or workplaces and indoor concentrations of nicotine and/or RSP from selected studies. In 1986 Leaderer and Hammond (33) studied 96 residences in the Onondaga and Suffolk counties of New York State. They found linear relations between diary-reported total number of cigarettes smoked during 1 week in the residences and 1-week residential nicotine and RSP levels. Monitoring of nicotine and RSP was conducted in the main living area (living room or family room). These relations are demonstrated in Figure 5 . In addition, the nicotine and RSP concentrations were highly correlated and the RSP/nicotine ratio was 10.8.
Concluding Remarks
Two types of estimates are needed for a quantitative risk assessment of the health effects resulting from occupational ETS exposure: an unbiased estimate of the exposureeffect (or dose-response) relation between ETS and the health effect of interest, and estimates of the distribution of ETS levels in different workplaces. The estimate of the exposure-effect relation can be derived either from individual studies or from a meta-analysis or pooled analysis of individual data. By combining the exposure-effect relation with information on exposure distribution for a population of interest, we can calculate the proportions of the exposed disease cases (attributable proportion or etiologic fraction) and of all disease cases in this population (population-attributable proportion) attributable to occupational ETS exposure. We can also estimate the excess number of cases resulting from specified exposure conditions. Several dimensions of the exposure profile should be taken into account when assessing ETS exposure for estimating an exposureeffect relation. These include the magnitude of exposure and the biologically relevant time specificity of exposure (9) . The magnitude of exposure is determined by the ETS source strength, the environmental factors that modify concentrations, and the duration of exposure. The magnitude of biologically effective dose is determined also by factors affecting uptake of ETS and metabolism of compounds absorbed. Time specificity-related issues include consideration of the latency period for each health outcome of interest, the time-exposure profile relevant for different disease mechanisms, and the sensitive age period with regard to different health effects. The most appropriate indicator of ETS for exposure assessment for each health outcome (33) . bOne pack = 20 cigarettes. depends on the time specificity dimensions mentioned and on the time period that can be assessed with different methods.
Consideration of these different aspects of exposure profile is critical, since exposure assessment that does not take into account these aspects will reduce the sensitivity of the study to detect a true effect or at least it will underestimate the effect. An attempt to quantify the magnitude of exposure increases the power of the study to detect adverse effects. Time specificity of exposure in relation to outcome has often received less attention, especially in cross-sectional and case-control studies, and can be a source of a failure to detect health effects. For example, assessing only current ETS exposure in studies of lung cancer risk may lead to a false negative result if current exposure is not related to earlier exposure that is more relevant, given the long latency period of lung cancer. Assessing average ETS levels during a specified time period may not be related to exacerbations of asthma, whereas high peak exposures may be followed by increased episodes of asthma exacerbation. A third example is studies of effects of fetal exposure; the developmental period during which exposure takes place is essential with regard to detecting health effects. In three extensive reviews of indoor air nicotine and/or RSP concentrations in different microenvironments, the levels were essentially comparable between work and residential environments in the United States and other countries (1, 12, 25) . According to the most recent review of nicotine concentrations, the levels are slightly higher in the workplace compared to residential environments where smoking takes place (25) . The nicotine levels are somewhat higher in offices compared to blue-collar occupational settings, probably attributable to larger size and better ventilation of nonoffice work areas. In some special work environments such as bars and restaurants, the levels may be extremely high. Data from experimental and field studies show good agreement between ETS marker indoor concentrations predicted from cigarette smoking with models applying mass balance law and measured concentrations of RSP, CO, and nicotine. Some data are available on the relations between questionnairereported rate of smoking and indoor ETS marker concentrations. However, more research is needed to achieve more accurate and precise estimates of the relations between questionnaire-reported amount of smoking and indoor air marker concentrations, since most of the health effect studies have based ETS exposure assessment on questionnaires. When better estimates are obtained, information on the distribution of ETS exposure levels in different occupational settings can be better used for assessing health risks due to workplace ETS exposure.
